Article 2
1. When allowing the placing on the market of biocidal products containing temephos in accordance with Article 1, France shall ensure that the following conditions are complied with: (a) continued use is only possible under the conditions that biocidal products containing temephos are approved for the intended essential use; (b) the continued use is only accepted so far as it has no unacceptable effect on human or animal health or on the environment; (c) all appropriate risk reduction measures are imposed when granting approval; (d) such biocidal products remaining on the market after 1 September 2006 are relabelled in order to match the restricted use conditions; (e) where appropriate, alternatives for such uses are being sought by the holders of the approvals or by France. 2. France shall inform the Commission annually on the application of paragraph 1 and in particular on the actions taken pursuant to point (e) of that paragraph.